Scroll for more


Mar 1, 2018 benevolentai

A view from the labs

A new view brings a new perspective… …its late February and I am sitting in our new Cambridge office looking at an unusually snowy scene of lawns and woodland.

Feb 21, 2018 benevolentai

RESEARCH | Exploring deep recurrent models with reinforcement learning for molecule design

The design of small molecules with bespoke properties is of central importance to drug discovery. However significant challenges yet remain for computational methods, despite recent advances such as deep recurrent networks and reinforcement learning strategies for sequence generation, and it can be difficult to compare results across different works.

Jan 16, 2018 benevolentai

What if AI could take your research to the next level?

Most scientific breakthroughs are made by analysing data, but we live in a world where the exponential growth of scientific research data makes the discovery of new drugs and treatments for disease very difficult. 

Nov 2, 2017 jackie hunter

The AI Industry Must Embrace Diversity Or Risk Reinforcing The Status Quo

Professor Jackie Hunter, CEO of BenevolentBio, writes for The Huffington Post on diversity in the AI industry and how it has the chance to embrace it or risk going the same way as many other industries.

Oct 25, 2017 bear

Bear - The Interns' Departure

A few months ago, some humans from UCL (presumably the Universal Canine League) came and sat near my bed-desk and started scribbling on whiteboards without so much as a second glance at the tennis ball I dropped on to their workbench. I was even told off for disturbing them while they work – the cheek of it!

Oct 5, 2017 jackie hunter

Why it’s essential the AI sector reflects society at large

Jackie Hunter explains why we need to encourage diversity in AI in a co-ordinated effort across the home, at school, at university and into the workplace.

Oct 3, 2017 benevolentai

Are You Looking For A Faster Horse In Drug Discovery?

As we all work busily in our own corners of drug discovery, be it in Pharma, biotech or academia, ask yourself the question – are you just pushing that horse a little more or are you genuinely imagining and creating the model T of the 21st century?

May 31, 2017 benevolentai

Join the special interest group on artificial intelligence in biomedicine.

Initiated after the first Artificial Intelligence (AI) in Bioscience Symposium in 2016, the special interest group on AI in Biomedicine aims at stimulating debate and encouraging collaboration between experts in life science and AI.

May 2, 2017 bear

Paw perks at BenevolentAI

Dear Country Cousin, Long time, no bark! Sincerest apologies – I’ve been so busy with work that I simply haven’t had the time to write. How is the sheep herding business treating you? – I imagine its been a busy time, what with lambing just gone and the sheep dog trial season kicking off in earnest shortly.

Apr 10, 2017 jackie hunter

Thoughts on Science Policy

On the surface science policy may appear to be rather a dry subject, but it is fundamental to academic research and its positive knock-on effect for innovation in industry. 

Feb 23, 2017 bear

Bear necessities - a day in the life of an AI office dog

An increasingly large number of humans are walking through the doors at Benevolent AI HQ, fresh faced and ready to join the team

Feb 20, 2017 jackie hunter

Wither pharmaceutical innovation?

Let’s talk pharmaceutical innovation, and in doing so let’s be honest and perhaps a little controversial. Last year the CEO of Regeneron, Leonard Schleifer, stood up at the Forbes Healthcare Summit in New York and said something surprisingly candid and revealing.

Feb 16, 2017 bear

Undigging the Hackathon

People bustling madly, sleepovers at the office, and tables full of delicious pasta. This can only mean one thing – dinner time.  Oh, apparently it’s because Benevolent just hosted its first ever Hackathon?

Feb 8, 2017 benevolentai

What's in a name? Our first clinical trial

Recently we welcomed the news that we have officially selected a study name for BenevolentAI's first clinical trial.

Jan 11, 2017 kenneth mulvany

Is AI morality asleep at the wheel?

In an age where you could soon be legally (and safely) asleep at the wheel thanks to driverless cars will morality in AI go the same way – is the principle of ethics in AI asleep at the wheel?

Dec 21, 2016 jackie hunter

I'm buying science presents for Christmas this year

It’s the last week before Christmas and a good time for reflection, to pause for breath and to think about what the next year will bring.

Dec 1, 2016 kenneth mulvany

Why… …we are called ‘Benevolent’?

We are developing and applying AI technology to enhance and accelerate scientific discovery by turning the world’s mass of highly fragmented scientific information into new insight and useable knowledge that ultimately benefits society.   

Nov 5, 2016 jackie hunter

In five years' time… Key trends in AI healthcare

10 years ago I attended a symposium looking at the future of pharmacology and healthcare.

Oct 7, 2016 jackie hunter

What happens when you put expert human brains in a room to discuss machine brains?

These are truly exciting times for artificial intelligence (“AI”) and bioscience. This month, together with The Crick and Turing Institutes and the Wellcome Trust, we co-hosted the first of what we anticipate will be an annual symposium on ‘Artificial Intelligence in Bioscience’.